论文部分内容阅读
本文对2型糖尿病患者207例行B超检查,对确诊为脂肪肝患者52例进行分析,探索其发病情况与病程、血脂、血糖和体重指数的关系.1 临床资料1.1 根据WHO糖尿病诊断标准确诊的2型糖尿病病人207例,女118例,男89例,年龄42～80岁,平均61岁,糖尿病病程半年～14年,平均7.2年,经腹部B超探查诊断为脂肪肝52例,将207例2型糖尿病患者分为脂肪肝组和无脂肪肝组.1.2 方法:(1)B超仪器为LoGIQ 400超声诊断仪,探头频率为3.5NHz,B超诊断标准据肝脏形态、回声和肝静脉等声象图改变诊断脂肪肝.(2)对207例患者抽空腹静脉血用7170自动生化分析仪行空腹血糖、血脂、肝功能检测;(3)体重指数=体重÷身高(M~2),以体重指数<24天为正常,>24天为肥胖.
In this paper, 207 patients with type 2 diabetes mellitus B-ultrasound, diagnosed with fatty liver in 52 patients were analyzed to explore the incidence and duration of disease, blood lipids, blood glucose and body mass index.1 Clinical data 1.1 According to the WHO diagnostic criteria for diabetes Of 207 patients with type 2 diabetes mellitus, 118 women, 89 patients, aged 42 to 80 years, mean 61 years, duration of diabetes for half a year to 14 years, an average of 7.2 years, diagnosed by abdominal B- 207 patients with type 2 diabetes were divided into fatty liver group and non-fatty liver group.1.2 Methods: (1) B ultrasound instrument LoGIQ 400 ultrasonic diagnostic apparatus, the probe frequency is 3.5NHz, B ultrasound diagnostic criteria according to liver morphology, echo and liver (2) Fasting blood glucose, blood lipids and liver function were measured with 7170 automatic biochemical analyzer on 207 patients with fasting venous blood; (3) Body mass index = body weight ÷ height (M ~ 2 ) To body mass index <24 days as normal,> 24 days for obesity.